In brief, one of the first groundbreaking achievements was the Prkdcscid (protein kinase, DNA activated, catalytic polypeptide) mutation on the CB17 mouse strain, commonly named as SCID (severe combined immunodeficiency) (103). The gene discussed is PRKDC; the disease is severe combined immunodeficiency.